Nuvoton Releases 4th Generation of “Gerda (TM),” Automotive HMI Display IC Series, in 3 Variants
KYOTO, Japan, June 6, 2025 /PRNewswire/ — Nuvoton Technology Corporation Japan (NTCJ) will start the mass production of its 4th-generation automotive HMI (Human-Machine... Read more.
JETOUR G700’s Historic Debut at the 2025 Taklimakan Rally
WUHU, China, June 6, 2025 /PRNewswire/ — In the recently concluded 2025 Taklamakan Rally (TAR), the JETOUR G700 achieved remarkable results. Driven by Li... Read more.
Hemispherian receives positive opinion for Orphan Medicinal Product Designation in the EU for GLIX1 in glioma
OSLO, Norway, June 6, 2025 /PRNewswire/ — Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, announced... Read more.
HIMSS Unites Global Healthcare Leaders to Shape the Future of Care: From Paris to Kuala Lumpur to Las Vegas
ROTTERDAM, Netherlands, June 6, 2025 /PRNewswire/ — Thousands of health and technology leaders will gather to share critical health technology insights to... Read more.
HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid
JAVENÉ, France, June 6, 2025 /PRNewswire/ — On the occasion of National Bioproduction and Biomedicines Day (JNBB), which enjoys the high patronage of the... Read more.
iQIYI pioneers digital asset commercialization, leading the charge in scalable virtual production
BEIJING, June 6, 2025 /PRNewswire/ — iQIYI, China’s leading online entertainment platform, recently partnered with premier 3D digital asset trading platform CGModel.com... Read more.
Jen Easterly to Keynote 2025 Hybrid Identity Protection Conference
Easterly joins identity-first defenders at the award-winning conference, October 7–9 in Charleston, SC HOBOKEN, N.J., June 6, 2025 /PRNewswire/ — Semperis,... Read more.
Stina Ehrensvärd from Sweden named EY World Entrepreneur Of The Year™ 2025
MONACO, June 6, 2025 /PRNewswire/ — Stina Ehrensvärd, founder of Yubico, was named the EY World Entrepreneur Of The Year 2025 at an award ceremony held... Read more.
YolTech Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for YOLT-101, an In Vivo Base Editing Therapy to Treat Heterozygous Familial Hypercholesterolemia (HeFH)
SHANGHAI, June 5, 2025 /PRNewswire/ — YolTech Therapeutics, a clinical-stage biotechnology company developing in vivo genome editing therapies, today announced... Read more.
Kelun-Biotech Announces Approximately US$250 Million Placement
CHENGDU, China, June 5, 2025 /PRNewswire/ — On June 5, 2025, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech” or the “Company”,... Read more.